We just published our findings and recommendations for researchers to better protect the privacy of research participants when sharing open data. Examining over 2,000 public datasets from papers using human participants, we found that 5-10% contained information that could potentially re-identify participants.

Continue reading

Author's picture

Richard Klein

Clinical Data Scientist at the Food and Drug Administration analyzing safety signals in New Drug Applications. Former academic who focused on replication and methods for robust science in Psychology. raklein22@gmail.com

Clinical Data Scientist @ FDA

Silver Spring, Maryland